Table 2.
Treatment Characteristics
| Characteristic | EGFR+/KRAS- | EGFR-/KRAS+ | EGFR-/KRAS- |
|---|---|---|---|
| Total tumor treated volume (cm3), median (range) | 0.57 (0.05-10.10) | 0.69 (0.14-7.4) | 0.92 (0.04-8.38) |
| Largest site treated volume (cm3), median (range) | 0.45 (0.05-7.4) | 0.38 (0.08-4.80) | 0.59 (0.04-6.0) |
| # of lesions treated: | |||
| 1 | 3 (33.3%) | 5 (33.3%) | 21 (48.8%) |
| 2 | 2 (22.2%) | 4 (26.7%) | 9 (20.9%) |
| 3 or more | 4 (44.4%) | 6 (40.0%) | 13 (30.2%) |